API business: a burden to Guangji Pharmaceutical's performance in H1 2015

Summary: In H1 2015, Guangji Pharmaceutical continued to lose money because the performance of its API series, including VB2 and VB6, was unsatisfactory.On 18 Aug., 2015, Hubei Guangji Pharmaceutical Co., Ltd. (Guangji Pharmaceutical) published its s...

Vitamins China E-News 201508

www.cnchemicals.com